Abstract
This report analyzes the US market for Intranasal Drug Delivery in US$
Million. The product is analyzed by the following Therapeutic Areas: Allergic
Infections, Analgesics, Osteoporosis, and Vaccinations. Annual forecasts are
provided for the period of 2000 through 2015. The report profiles 78 companies
including many key and niche players such as Aegis Therapeutics LLC, Alza
Corporation, AptarGroup, Inc., Archimedes Pharma, AstraZeneca Plc, MedImmune,
Inc., Bayer Consumer Care, Bespak Plc, GlaxoSmithKline Plc, Intranasal
Therapeutics, Inc., Javelin Pharmaceuticals, Inc., Kurve Technology, Inc.,
Nastech Pharmaceutical Company, Inc., Novartis AG, OptiNose AS, Pfizer, Inc.,
Rexam Plc, Schering-Plough Corporation, Sanofi-Aventis S.A., and Unigene
Laboratories, Inc. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
View Cart
